Commentary

Video

Ross Margulies Previews 2024 AMCP Annual Conference

Legal expert in health care, partner, and cochair of the health care coverage and reimbursement practice at Foley Hoag LLP, Ross Margulies discusses his excitement and expectations as a featured speaker at the upcoming 2024 AMCP Annual Conference.

The Academy of Managed Care Pharmacy (AMCP) is hosting its annual conference in New Orleans this year from April 15-18, and will be attracting over 4000 attendees.

One of the featured speakers is Ross Margulies, a health care attorney and partner at Foley Hoag LLP. Margulies will be focusing on health care reform and its impact on pharmacy benefit managers (PBMs). In this interview, he shares his expectations for the conference and the key takeaways he hopes attendees will gain.

Transcript

What are you looking forward to most at AMCP?

I've been to AMCP conferences many times over the last 6 or 7 years probably. Frankly, what I love about AMCP is it's one of the few forums where you get together different stakeholders, pharmacies, managed care pharmacies, community pharmacies, PBMs, manufacturers, and you talk about some of the tough issues. I'm talking about one of them, which is PBM reform. You know, it's pretty rare these days that you get diverse perspectives, and I honestly think a lot of really interesting conversations happen because of that.

What are you hoping attendees can take away from the meeting this year?

With respect to PBM reforms, I'd like my attendees to know what Congress is considering because it's filled with a lot of jargon, it’s very confusing. But I think the chance that there is going to be some type of PBM reform is pretty likely. No matter where you are on the drug supply chain, understanding what those provisions are and how they impact you is going to be really necessary, so that's my goal.

Related Videos
Monica Kraft, MD, ATSF.
Michael Arzt, MD.
Ravin Ratan, MD, MEd, MD Anderson
Dr Ajay Goel
Julie Linton, MD, FAAP.
Jan Hedner, MD, PhD.
Dr Migvis Monduy
Kimberly Westrich, MA, chief strategy officer of the National Pharmaceutical Council
Amy Shapiro, MD
Adam Benjafield, PhD.
Related Content
CH LogoCenter for Biosimilars Logo